The HCPLive Gastroenterology condition center page is a comprehensive resource for clinical news and insights on digestive and GI conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for C difficile, IBS and IBD, Crohn's disease, and more.
November 22nd 2024
The supplemental Biologics License Application is supported by the phase 3 ASTRO study of guselkumab SC induction therapy in ulcerative colitis.
International Fecal Bank Feasible
Fecal microbiota transplantation (FMT) is a proven therapy for recurrent C. difficile infection. A team of researchers from OpenBiome outlined plans for a depository for frozen stool from screened donors. The goal is to have a consistent and safe product for use by clinicians who treat patients with this ailment.
Diabetes Increases IBD Infection Risk
Patients with inflammatory bowel diseases are sometimes treated with immunosuppressive drugs, particularly if they have a significant co-morbidity. A Boston team of researchers found that when that co-morbidity is diabetes, patients are at greater risk of coming down with infections.
5 New Hepatitis C Drugs Added to WHO "Essentials" List
May 13th 2015The essential medicines list put out by the World Health Organization (WHO) now includes five new hepatitis C drugs that show great promise in curing the disease in millions of people. However, the WHO also warned financial stumbling blocks could greatly hinder efforts to make treatment equitable throughout the world.
Hepatitis C and Injection Drug Use Top Targets of CDC Prevention Efforts
May 13th 2015In a continuing effort to curb the spread of hepatitis C among the riskiest populations, government health officials recently held a webinar to discuss links between opioid injection drug use and increased cases of the liver disease.
Helicobacter Pylori and Type 2 Diabetes Mellitus: More GI Upset with Metformin
May 12th 2015China's type 2 diabetes mellitus (T2DM) epidemic continues to be a pervasive, costly health care issue, with proportions surpassed only by epidemic here in the US. The majority of T2DM treatment guidelines recommend metformin as the first-line anti-hyperglycemic agent for diabetes management due to its relative safety, tolerability, and cost-effectiveness.
Eat Fiber: One Simple Message for Weight Loss
May 11th 2015This study was a randomized, controlled trial of 240 adults with metabolic syndrome who were assigned to follow either the single-component dietary recommendation of increased fiber consumption (≥30g/d), or the multi-component American Heart Association (AHA) dietary guidelines. The primary outcome measure was weight loss at 12 months.
Q&A With Colleen Kelly, MD, From Brown Alpert Medical School: Diagnosing C-Difficile
A growing concern in the field of gastroenterology has been the growing number of patients diagnosed with Clostridium Difficile. The condition, which can have a negative impact on a patient's quality of life can include symptoms like severe diarrhea.
The End of SGR: What Took So Long?
May 8th 2015For more than a decade, it has been an annual ritual to read headlines about a crisis brewing in Congress as it struggled to avert a looming Medicare disaster stemming from the imminent pay cut to Medicare physicians mandated by the "SGR". Like a broken record each time, spurred by warnings of physician groups of the dire consequences the slash in Medicare fees would have on medical practices and Medicare patients, Congress scrambled at the 12th hour to put off the mandated cuts for another year.
Relaxation Responses for Gastrointestinal Disorders
Relaxation responses physiologic states of deep rest induced by practices such as meditation, yoga, and prayer were reported to positively trigger symptom improvement and gene expression changes within patients afflicted with gastrointestinal disorders like irritable bowel syndrome and inflammatory bowel disease.
Chronic Itch: Gastrointestinal Peptides as Possible Contributors
May 5th 2015Chronic itch (itch last 6 weeks or longer) is a clinical challenge, and is associated with a number of dermatologic, systemic, neuropathic, and psychogenic causes. Transmission of the itch sensation is similar to that of pain, but distinct in several ways. Scientists have found itch-specific neuronal pathways that when activated, cause considerable discomfort for patients. Current available treatments, however, are still more trial-and-error than evidence-based.
Survey Finds US Hospitals Falling Short on Preventing C. Difficile Infection
May 5th 2015A survey of 571 US hospitals regarding practices used to prevent Clostridium difficile infection indicates that nearly half of the facilities appear to not be taking steps to prevent the infection that kills nearly 30,000 people and sickens hundreds of thousands more each year, despite strong evidence that these steps work.
GIST Patients Prone to More Cancer
Approximately 1 in 6 patients suffering from gastrointestinal stromal tumors (GIST) are likely to develop malignant cancers before or after diagnosis, according to the inaugural population-based study recently conducted by researchers at the UC San Diego School of Medicine.